resveratrol has been researched along with pepstatin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bobrovs, R; Borysov, OV; Jaudzems, K; Jirgensons, A; Kanepe-Lapsa, I; Pantelejevs, T; Rasina, D; Stakanovs, G; Tars, K | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
2 other study(ies) available for resveratrol and pepstatin
| Article | Year |
|---|---|
2-Aminoquinazolin-4(3H)-one based plasmepsin inhibitors with improved hydrophilicity and selectivity.
Topics: Aspartic Acid Endopeptidases; Binding Sites; Cathepsin D; Hydrophobic and Hydrophilic Interactions; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Plasmodium falciparum; Protease Inhibitors; Protozoan Proteins; Quinazolinones; Solubility; Structure-Activity Relationship | 2018 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |